A team of researchers at the Indian Institute of Technology (IIT) Roorkee on Tuesday announced the development of a ...

Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...

Researchers at the IIT Roorkee have developed a next-generation antibody discovery platform that has the potential to transform diagnostics in India ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. In April 2021, the FDA approved the 100th monoclonal ...

In the last few years, multispecific antibodies, such as bispecific, trispecific, and tetraspecific antibodies, have become the breakthrough stars in antibody therapeutics. Compared with conventional ...

With a comprehensive overview of the developments in immunotherapeutics, this webinar focuses on the utilization of B cells in the production of monoclonal antibodies (mAbs) comparing conventional ...

This study presents a comprehensive approach for assessing multiple quality attributes of antibody-oligonucleotide conjugates ...

Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...

For therapies based on monoclonal antibodies (mAbs), bioprocessors continually search for ways to improve the development process. Machine learning (ML) offers one useful tool. As Mariano Nicolas Cruz ...

iBio (IBIO) in collaboration with AstralBio announced the development of an antibody that inhibits the function of Activin E, a promising therapeutic target for cardiometabolic disorders and obesity ...

A lack of targeting specificity has been a long-running problem for cytotoxic anticancer agents, with excess side effects limiting their effectiveness. Scientists have turned to antibodies, and their ...